Growth Metrics

InMode (INMD) Liabilities and Shareholders Equity (2018 - 2026)

InMode recorded quarterly Liabilities and Shareholders Equity of $750.8 million in Q1 2026, down 2.03% quarter-over-quarter from $766.4 million in Q4 2025, and up 6.54% year-over-year from $704.7 million in Q1 2025.

InMode's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $750.8 million for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 6.54% year-over-year to $750.8 million; the TTM figure through Mar 2026 stood at $3.0 billion (down 6.74% YoY), while the FY2025 annual figure was $766.4 million, down 2.45% from the prior year.
  • Liabilities and Shareholders Equity came in at $750.8 million for Q1 2026 at InMode, down from $766.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $891.7 million in Q1 2024 to a low of $464.5 million in Q1 2022.
  • A 5-year average of $723.4 million and a median of $734.6 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity surged 44.17% in 2023 and declined 20.97% in 2025, its largest moves.
  • InMode's Liabilities and Shareholders Equity stood at $644.4 million in 2022, then surged by 33.97% to $863.3 million in 2023, then declined by 8.99% to $785.7 million in 2024, then fell by 2.45% to $766.4 million in 2025, then retreated by 2.03% to $750.8 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $750.8 million, $766.4 million, and $734.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 InMode 3.41 -384.57 Mn 61.55 Mn 750.84 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 750.84 Mn
Dec 31, 2025 766.43 Mn
Sep 30, 2025 734.61 Mn
Jun 30, 2025 708.35 Mn
Mar 31, 2025 704.74 Mn
Dec 31, 2024 785.67 Mn
Sep 30, 2024 824.03 Mn
Jun 30, 2024 859.84 Mn
Mar 31, 2024 891.74 Mn
Dec 31, 2023 863.29 Mn
Sep 30, 2023 793.53 Mn
Jun 30, 2023 734.08 Mn
Mar 31, 2023 669.61 Mn
Dec 31, 2022 644.41 Mn
Sep 30, 2022 578.98 Mn
Jun 30, 2022 523.21 Mn
Mar 31, 2022 464.47 Mn
Dec 31, 2021 478.54 Mn
Sep 30, 2021 447.66 Mn
Jun 30, 2021 383.03 Mn
Mar 31, 2021 337.29 Mn
Dec 31, 2020 295.76 Mn
Sep 30, 2020 274.14 Mn
Jun 30, 2020 238.02 Mn
Mar 31, 2020 229.70 Mn
Dec 31, 2019 218.39 Mn
Sep 30, 2019 189.77 Mn
Jun 30, 2019 102.56 Mn
Dec 31, 2018 81.06 Mn